Burjeel Holding reported AED 2.8 billion in revenue for the first half of the year the company said in a statement released this week. The figure reflects sustained demand for specialised care and the ramp-up of new assets across its hospital and medical-centre segments. Executives highlighted robust patient footfall that persisted despite seasonal factors a company assessment found. The healthcare group which operates multiple facilities in the UAE has pursued growth through both organic expansion and targeted acquisitions in recent years according to industry filings.
The company’s hospitals segment accounted for the majority of revenue in the period delivering an increase driven by higher inpatient and outpatient volumes the statement indicated. Medical centres posted stronger percentage growth from the addition of more than a dozen new sites and a rise in outpatient visits. Burjeel Holding has benefited from broader regional healthcare investment trends with the UAE market showing consistent expansion in private-sector capacity Central Bank of Kuwait data on GCC economies places healthcare among the faster-growing service segments. The first-half performance builds on earlier quarterly results that showed revenue climbing steadily through 2025 and into 2026.
Net profit for the period rose substantially on the back of operational efficiencies and cost optimisation the company reported. EBITDA margins also improved as a result of better asset utilisation across the network. Burjeel Holding has maintained a focus on high-acuity services including oncology cardiology and orthopaedics which command higher reimbursement rates according to sector analysts. The group continues to invest in advanced medical technology to differentiate its offerings from competitors.
Expansion into Saudi Arabia forms a central element of Burjeel Holding’s medium-term strategy the statement noted. The company has secured licences and begun preparatory work for new facilities in the kingdom where demand for private healthcare is rising in line with Vision 2030 goals. S&P Global Ratings which reviewed the group’s credit profile in June 2026 placed its adjusted EBITDA at roughly AED 1.1 billion on full-year revenue of AED 5.5 billion illustrating the scale of operations. Management expressed confidence that the Saudi entry would contribute meaningfully to future revenue streams.
Patient visits across the group’s facilities exceeded one million in the first quarter alone according to the latest operational metrics. The company attributed the increase to greater awareness of its specialised services and partnerships with insurance providers. Burjeel Holding operates a portfolio that includes flagship hospitals in Abu Dhabi and Dubai as well as a growing chain of outpatient centres. Further growth in patient numbers is expected as additional capacity comes online in the second half of the year.
The healthcare provider listed on the Abu Dhabi Securities Exchange has delivered consistent revenue growth since its public debut. Industry benchmarks compiled by Mordor Intelligence project the GCC private healthcare market to expand at a mid-to-high single-digit rate through the end of the decade supported by population growth and medical tourism. Burjeel Holding’s first-half results align with that trajectory the company said. Executives indicated that capital expenditure plans remain on track to support further network development.
